Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancer - PubMed (original) (raw)

Review

Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancer

George Coukos et al. Adv Exp Med Biol. 2007.

No abstract available

PubMed Disclaimer

Similar articles

• Cell adhesion in ovarian cancer.
  Elmasri WM, Casagrande G, Hoskins E, Kimm D, Kohn EC. Elmasri WM, et al. Cancer Treat Res. 2009;149:297-318. doi: 10.1007/978-0-387-98094-2_14. Cancer Treat Res. 2009. PMID: 19763442 Review. No abstract available.
• Role of vascular leukocytes in ovarian cancer neovascularization.
  Balint K, Conejo-Garcia JR, Buckanovich R, Coukos G. Balint K, et al. Adv Exp Med Biol. 2008;622:273-80. doi: 10.1007/978-0-387-68969-2_22. Adv Exp Med Biol. 2008. PMID: 18546635 Review.
• Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
  Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G. Zhang L, et al. Cancer Res. 2003 Jun 15;63(12):3403-12. Cancer Res. 2003. PMID: 12810677
• Vascular leukocytes contribute to tumor vascularization.
  Conejo-Garcia JR, Buckanovich RJ, Benencia F, Courreges MC, Rubin SC, Carroll RG, Coukos G. Conejo-Garcia JR, et al. Blood. 2005 Jan 15;105(2):679-81. doi: 10.1182/blood-2004-05-1906. Epub 2004 Sep 9. Blood. 2005. PMID: 15358628
• [Angiogenesis under Delta-Notch couple control].
  Suchting S, Freitas C, Eichmann A. Suchting S, et al. Med Sci (Paris). 2007 Apr;23(4):347-8. doi: 10.1051/medsci/2007234347. Med Sci (Paris). 2007. PMID: 17433219 French. No abstract available.

Cited by

• Immune Modulation of Innate and Adaptive Responses Restores Immune Surveillance and Establishes Antitumor Immunologic Memory.
  Alvero AB, Fox A, Madina BR, Krady MM, Gogoi R, Chehade H, Nakaar V, Almassian B, Yarovinsky TO, Rutherford T, Mor G. Alvero AB, et al. Cancer Immunol Res. 2024 Feb 2;12(2):261-274. doi: 10.1158/2326-6066.CIR-23-0127. Cancer Immunol Res. 2024. PMID: 38078853 Free PMC article.
• Macrophages enhance Vegfa-driven angiogenesis in an embryonic zebrafish tumour xenograft model.
  Britto DD, Wyroba B, Chen W, Lockwood RA, Tran KB, Shepherd PR, Hall CJ, Crosier KE, Crosier PS, Astin JW. Britto DD, et al. Dis Model Mech. 2018 Nov 29;11(12):dmm035998. doi: 10.1242/dmm.035998. Dis Model Mech. 2018. PMID: 30396905 Free PMC article.
• Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.
  Fox BA, Sanders KL, Chen S, Bzik DJ. Fox BA, et al. Trends Parasitol. 2013 Sep;29(9):431-7. doi: 10.1016/j.pt.2013.07.001. Epub 2013 Aug 5. Trends Parasitol. 2013. PMID: 23928100 Free PMC article. Review.
• Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.
  Baird JR, Fox BA, Sanders KL, Lizotte PH, Cubillos-Ruiz JR, Scarlett UK, Rutkowski MR, Conejo-Garcia JR, Fiering S, Bzik DJ. Baird JR, et al. Cancer Res. 2013 Jul 1;73(13):3842-51. doi: 10.1158/0008-5472.CAN-12-1974. Epub 2013 May 23. Cancer Res. 2013. PMID: 23704211 Free PMC article.
• Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.
  Schmid MC, Varner JA. Schmid MC, et al. J Oncol. 2010;2010:201026. doi: 10.1155/2010/201026. Epub 2010 May 16. J Oncol. 2010. PMID: 20490273 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Medical

  • MedlinePlus Health Information